Permitting lawful prescription of crystalline polymorph psilocybin under FDA recommendations
West Virginia SB906 allows for the lawful prescription, distribution, and marketing of crystalline polymorph psilocybin if it is approved by the United States Food and Drug Administration and rescheduled by the United States Drug Enforcement Administration. This bill amends the Code of West Virginia to include provisions for the lawful prescription of psilocybin, aligning with FDA recommendations.
Included in complete analysis
- Overview
- Core Provisions
- Implementation
- Impact
- Legal Framework
- Critical Issues
See what it does, who it affects, and the critical issues in plain language. Free, 30 seconds.